Skip to main content
Clinical Trials/JPRN-UMIN000005647
JPRN-UMIN000005647
Completed
Phase 2

A prospectve study to evaluate the efficacy of pregabalin for chemotherapy-induced peripheral nueralgia - Pregabaalin for chemotherapy-induced peripheral nueralgia

Tokyo University, Dep. of Hematology and Oncology0 sites50 target enrollmentJune 1, 2011

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Patients who suffers from peripehral neuralgia which is induced by antineaoplastic agents that were adeministered for therapy of hematological malignancies
Sponsor
Tokyo University, Dep. of Hematology and Oncology
Enrollment
50
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 1, 2011
End Date
TBD
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Tokyo University, Dep. of Hematology and Oncology

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. decreased renal function (creatinine clearance equal to 60mL/min or less) 2\. ocular disturbances including vision abnoramlity 3\. underlying diabetes mellitus or postherpetic neuralgia 4\. with previous history of pregabalin administration

Outcomes

Primary Outcomes

Not specified

Similar Trials